Covered recipient · General Payments record
PAYMAN SADEGHI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,346.32
- Reported across 216 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $777.25 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $364.51 | 19 |
| PFIZER INC. | $196.91 | 9 |
| Lilly USA, LLC | $85.53 | 4 |
| SCILEX PHARMACEUTICALS INC. | $66.77 | 3 |
| ARGENX US, INC. | $24.26 | 1 |
| Lundbeck LLC | $23.37 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.91 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997029 | CMS |
| ABBVIE INC. | $20.45 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997031 | CMS |
| ABBVIE INC. | $23.64 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997033 | CMS |
| ABBVIE INC. | $27.78 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997035 | CMS |
| ABBVIE INC. | $5.63 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997037 | CMS |
| ABBVIE INC. | $30.66 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997039 | CMS |
| ABBVIE INC. | $30.12 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997041 | CMS |
| ABBVIE INC. | $23.81 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997043 | CMS |
| ABBVIE INC. | $13.50 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997045 | CMS |
| ABBVIE INC. | $14.18 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997047 | CMS |
| ABBVIE INC. | $2.90 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997049 | CMS |
| ABBVIE INC. | $19.79 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997051 | CMS |
| ABBVIE INC. | $24.06 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997053 | CMS |
| ABBVIE INC. | $17.81 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997055 | CMS |
| ABBVIE INC. | $5.16 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997057 | CMS |
| ABBVIE INC. | $22.41 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997059 | CMS |
| ABBVIE INC. | $24.05 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997061 | CMS |
| ABBVIE INC. | $26.07 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997063 | CMS |
| ABBVIE INC. | $15.58 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105997065 | CMS |
| ARGENX US, INC. | $24.26 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142109917 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.90 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134012029 | CMS |
| Lilly USA, LLC | $18.58 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135288687 | CMS |
| Lilly USA, LLC | $22.99 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135289293 | CMS |
| Lilly USA, LLC | $22.86 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135289297 | CMS |
| Lilly USA, LLC | $21.10 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135288682 | CMS |
| Lundbeck LLC | $23.37 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145964004 | CMS |
| PFIZER INC. | $19.45 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131560468 | CMS |
| PFIZER INC. | $15.79 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131565089 | CMS |
| PFIZER INC. | $20.26 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131662362 | CMS |
| PFIZER INC. | $20.64 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131666260 | CMS |
| PFIZER INC. | $24.66 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131774143 | CMS |
| PFIZER INC. | $23.23 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131883815 | CMS |
| PFIZER INC. | $25.87 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131929652 | CMS |
| PFIZER INC. | $19.89 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131145201 | CMS |
| PFIZER INC. | $27.12 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131004092 | CMS |
| SCILEX PHARMACEUTICALS INC. | $22.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136217750 | CMS |
| SCILEX PHARMACEUTICALS INC. | $22.76 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136239439 | CMS |
| SCILEX PHARMACEUTICALS INC. | $21.10 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136265841 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.